Vitamin D Clinical Pharmacology: Relevance to COVID-19 Pathogenesis
- PMID: 33148446
- PMCID: PMC7605797
- DOI: 10.1016/j.jnma.2020.09.152
Vitamin D Clinical Pharmacology: Relevance to COVID-19 Pathogenesis
Abstract
▪▪▪.
Keywords: ▪▪▪.
Copyright © 2020 National Medical Association. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Chicago.gov. 2020. https://www.chicago.gov/content/dam/city/sites/covid/reports/2020-05-11/... Available from:
-
- Clemens T.L., Adams J.S., Henderson S.L., Holick M.F. Increased skin pigment reduces the capacity of skin to synthesis of vitamin D3. Lancet. 1982;8263(1):74–76. - PubMed
-
- Matsouka L.Y., Wortsman J., Haddad J.G., Kolm P., Hollis B.W. Racial pigmentation and the cutaneous synthesis of Vitamin D. Arch Dermatol. 1991;127:536–538. - PubMed
-
- Campbell P.A., Wu Young M.Y., Lee R.C. Vitamin D3 may reduce severity of COVID-19 respiratory viral infection. BMJ. 2020:368.
-
- Laird E., Rhodes J., Kenny R.A. Vitamin D and inflammation: potential implications for severity of Covid-19. Ir Med J. 2020;113:1. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
